Sort
48,018 grants matching “immunotherapy”
Specific Adoptive Immunotherapy of Myeloid Malignancy
$467,429Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2012 · CA
Binding and Presentation of Lipid Antigens by CD1
$467,416Steven A Porcelli · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
PEDIATRIC PHASE I TRIALS OF CYTOTOXIC &BIOLOGIC AGENTS
$467,415National Childhood Cancer Foundation · U01 · FY2000 · CA
UCLA Tumor Immunology Training Program
$467,412Michael A Teitell · University Of California Los Angeles · T32 · FY2014 · CA
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects
$467,405John B Sunwoo · Stanford University · R01 · FY2022 · DE
Miami Center for AIDS Research
$467,373Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2023 · AI
Attacking the Immunopeptidome of Ewing Sarcoma
$467,370Crystal Mackall · Stanford University · U01 · FY2023 · CA
Virally-induced tumorigenesis controlled by the microbiota
$467,351Tatyana V. Golovkina · University Of Chicago · R01 · FY2022 · CA
Virally-induced tumorigenesis controlled by the microbiota
$467,351Tatyana V. Golovkina · University Of Chicago · R01 · FY2023 · CA
TWO Compartment Models to Improve Brain Tumor Therapy
$467,324Oregon Health And Science University · R01 · FY2005 · NS
Characterizing the regulation of PD-1 ligands in head and neck cancer stem cells using an autologous humanized model with T cell education capability
$467,285Antonio Jimeno · University Of Colorado Denver · R01 · FY2017 · CA
Characterizing the regulation of PD-1 ligands in head and neck cancer stem cells using an autologous humanized model with T cell education capability
$467,285Antonio Jimeno · University Of Colorado Denver · R01 · FY2021 · CA
Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approaches
$467,263Billur Akkaya · Ohio State University · DP2 · FY2023 · AI
Binding and Presentation of Lipid Antigens by CD1
$467,196Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Binding and Presentation of Lipid Antigens by CD1
$467,196Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Binding and Presentation of Lipid Antigens by CD1
$467,196Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system
$467,188Anna Karolina Palucka · Jackson Laboratory · R01 · FY2015 · CA
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
$467,173Tatiana Kisseleva · University Of California, San Diego · R01 · FY2024 · DK
The Role of EBI3 in Regulating Gastritis and Gastric Carcinogenesis
$467,031Richard J Dipaolo · Saint Louis University · R01 · FY2020 · DK
Functional Immunomics Core
$466,901Bing Li · University Of Louisville · P20 · FY2023 · GM
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$466,898Xinna Zhang · Indiana University Indianapolis · R01 · FY2025 · CA
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$466,898Xinna Zhang · Indiana University Indianapolis · R01 · FY2023 · CA
Immune-based therapy against STEC intoxication and HUS
$466,864Saul R Tzipori · Tufts University Boston · R01 · FY2023 · AI
Novel IL-12 Gene Delivery Vehicles for Transformation of Solid Tumors
$466,837Seth M Pollack · Northwestern University At Chicago · R01 · FY2024 · CA
Amyloid-Lowering Small Molecule AB-Binding Agents in AD
$466,821William E Klunk · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AG